董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Adam Feinstein | 男 | Independent Director | 54 | 未披露 | 3032.42 | 2026-05-12 |
| Daniel Sollof | 男 | Independent Director | 43 | 未披露 | 未持股 | 2026-05-12 |
| Caroline Chu | 女 | Independent Director | 46 | 15.00万美元 | 17.68 | 2026-05-12 |
| Thomas Aaron | 男 | Independent Director | 64 | 15.00万美元 | 17.66 | 2026-05-12 |
| Kenneth Higgins | 男 | Independent Director | 61 | 15.00万美元 | 17.38 | 2026-05-12 |
| Michael Doyle | 男 | Chairman of the Board | 53 | 未披露 | 37.59 | 2026-05-12 |
| Yogesh Jashnani | 男 | Chief Executive Officer and Director | 44 | 498.06万美元 | 19.15 | 2026-05-12 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Michael Arthur | 男 | Chief Financial Officer | 38 | 未披露 | 未持股 | 2026-05-12 |
| Yogesh Jashnani | 男 | Chief Executive Officer and Director | 44 | 498.06万美元 | 19.15 | 2026-05-12 |
| Brent Wadman | 男 | General Counsel | 53 | 未披露 | 未持股 | 2026-05-12 |
董事简历
中英对照 | 中文 | 英文- Adam Feinstein
-
Adam Feinstein自2015年8月起在Surgery Partners股份有限公司（Surgery Partners, Inc.）担任董事。Feinstein先生联合创立了Vesey Street Capital Partners有限责任公司（Vesey Street Capital Partners, L.L.C.，一家健康保健服务私人股权基金，2014年）并且自那时起担任经营合伙人。2012-2014年，Feinstein先生担任LabCorp的公司发展、战略规划和首席执行官办事处的高级副总裁；在那之前担任Barclays Capital的股权研究总经理。他是ScribeAmerica（国家领先的医学文士提供商）和Imedex（领先的认可医学教育提供商）的董事会成员。Feinstein先生是特许金融分析师（CFA charterholder），拥有Maryland大学College Park分校史密斯学院的商业学士学位。他也完成了美国田纳西（Nashville）卫生保健委员会研究员计划。
Adam Feinstein has served as a member of the Board since June 2021 and served as lead independent director of the Board from March 2023 until November 2025. He previously served as the non executive chairman of the Board from September 2021 to January 2023 and as non executive chairman of the board of managers of Elite Body Sculpture from October 2018 until the IPO. Mr. Feinstein founded Vesey Street Capital Partners, L.L.C. in 2014 and serves as Managing Partner. He has served as chairman of the board of directors of QualityMetric, a provider of health and disease specific surveys, from August 2020 until August 2023. He has served as a member of the board of directors of Pathgroup, a leading pathology services company, since August 2016. Mr. Feinstein has served as a board member of Safecor Health, which provides pharmaceutical unit dose packaging services for hospitals and health systems, since August 2021. Most recently, Mr. Feinstein has served as a board member of Orthopedic Solutions Management, an orthopedic services provider, since May 2025, and Shemassian Academic Consulting, a provider of consulting services for students seeking admission to medical schools and other graduate programs, since February 2025. He has also served as a board member of ComplexCare Solutions, an independent health assessment and member engagement platform, since December 2024, and Inceptua Group, a leading provider of clinical trial supplies and related services, as well as global early access programs, since January 2024. He was a board member of Surgery Partners, Inc. (Nasdaq: SGRY) from September 2015 to December 2019 and Imedex, Inc. from July 2015 to August 2017. Prior to founding VSCP, Mr. Feinstein was the Senior Vice President of Corporate Development, Strategic Planning and Office of the Chief Executive Officer at LabCorp from June 2012 to August 2014. Prior to LabCorp, Mr. Feinstein served as the Managing Director in Equity Research at Barclays Capital/Lehman Brothers for 14 years. Mr. Feinstein is a CFA charterholder and has a B.S. in Business from the Smith School at the University of Maryland. He also completed the Nashville Healthcare Council Fellows program. - Adam Feinstein自2015年8月起在Surgery Partners股份有限公司（Surgery Partners, Inc.）担任董事。Feinstein先生联合创立了Vesey Street Capital Partners有限责任公司（Vesey Street Capital Partners, L.L.C.，一家健康保健服务私人股权基金，2014年）并且自那时起担任经营合伙人。2012-2014年，Feinstein先生担任LabCorp的公司发展、战略规划和首席执行官办事处的高级副总裁；在那之前担任Barclays Capital的股权研究总经理。他是ScribeAmerica（国家领先的医学文士提供商）和Imedex（领先的认可医学教育提供商）的董事会成员。Feinstein先生是特许金融分析师（CFA charterholder），拥有Maryland大学College Park分校史密斯学院的商业学士学位。他也完成了美国田纳西（Nashville）卫生保健委员会研究员计划。
- Adam Feinstein has served as a member of the Board since June 2021 and served as lead independent director of the Board from March 2023 until November 2025. He previously served as the non executive chairman of the Board from September 2021 to January 2023 and as non executive chairman of the board of managers of Elite Body Sculpture from October 2018 until the IPO. Mr. Feinstein founded Vesey Street Capital Partners, L.L.C. in 2014 and serves as Managing Partner. He has served as chairman of the board of directors of QualityMetric, a provider of health and disease specific surveys, from August 2020 until August 2023. He has served as a member of the board of directors of Pathgroup, a leading pathology services company, since August 2016. Mr. Feinstein has served as a board member of Safecor Health, which provides pharmaceutical unit dose packaging services for hospitals and health systems, since August 2021. Most recently, Mr. Feinstein has served as a board member of Orthopedic Solutions Management, an orthopedic services provider, since May 2025, and Shemassian Academic Consulting, a provider of consulting services for students seeking admission to medical schools and other graduate programs, since February 2025. He has also served as a board member of ComplexCare Solutions, an independent health assessment and member engagement platform, since December 2024, and Inceptua Group, a leading provider of clinical trial supplies and related services, as well as global early access programs, since January 2024. He was a board member of Surgery Partners, Inc. (Nasdaq: SGRY) from September 2015 to December 2019 and Imedex, Inc. from July 2015 to August 2017. Prior to founding VSCP, Mr. Feinstein was the Senior Vice President of Corporate Development, Strategic Planning and Office of the Chief Executive Officer at LabCorp from June 2012 to August 2014. Prior to LabCorp, Mr. Feinstein served as the Managing Director in Equity Research at Barclays Capital/Lehman Brothers for 14 years. Mr. Feinstein is a CFA charterholder and has a B.S. in Business from the Smith School at the University of Maryland. He also completed the Nashville Healthcare Council Fellows program.
- Daniel Sollof
-
Daniel Sollof自2021年6月起担任董事会成员，并于2018年10月起担任Elite Body Sculpture的董事会成员，直至IPO。Sollof先生于2014年8月加入VSCP，并担任该公司的普通合伙人。除了寻找和评估潜在的投资机会，Sollof先生还与VSCP的投资组合公司密切合作。2015年7月至2017年8月，他担任IMedex，Inc.的董事会成员。在加入VSCP之前，Sollof先生曾于2007年8月至2014年8月担任巴克莱银行资本/雷曼兄弟的副总裁兼研究分析师，专注于医疗保健设施和医疗用品与设备部门。在加入巴克莱银行资本/雷曼兄弟之前，Sollof先生于2005年9月至2007年7月在安永会计师事务所交易咨询服务集团担任估值和商业模型分析师。Sollof先生获得了加州大学圣地亚哥分校的管理科学学士学位，并且是CFA特许持有人。
Daniel Sollof has served as a member of the Board since June 2021 and served as a member of the board of managers of Elite Body Sculpture from October 2018 until the IPO. Mr. Sollof joined VSCP in August 2014 and serves as a General Partner for the firm. In addition to sourcing and evaluating potential investment opportunities, Mr. Sollof works closely with VSCP's portfolio companies. From July 2015 to August 2017, he served as a member of the board of directors of Imedex, Inc. Prior to joining VSCP, Mr. Sollof served as Vice President and Research Analyst for Barclays Capital/Lehman Brothers August 2007 to August 2014, focusing on the Healthcare Facilities and Medical Supplies & Devices Sectors. Prior to Barclays Capital/Lehman Brothers, Mr. Sollof worked as a Valuation and Business Modeling Analyst in the Transaction Advisory Services group at Ernst & Young from September 2005 to July 2007. Mr. Sollof received a B.S. in Management Science from the University of California — San Diego and is a CFA charterholder. - Daniel Sollof自2021年6月起担任董事会成员，并于2018年10月起担任Elite Body Sculpture的董事会成员，直至IPO。Sollof先生于2014年8月加入VSCP，并担任该公司的普通合伙人。除了寻找和评估潜在的投资机会，Sollof先生还与VSCP的投资组合公司密切合作。2015年7月至2017年8月，他担任IMedex，Inc.的董事会成员。在加入VSCP之前，Sollof先生曾于2007年8月至2014年8月担任巴克莱银行资本/雷曼兄弟的副总裁兼研究分析师，专注于医疗保健设施和医疗用品与设备部门。在加入巴克莱银行资本/雷曼兄弟之前，Sollof先生于2005年9月至2007年7月在安永会计师事务所交易咨询服务集团担任估值和商业模型分析师。Sollof先生获得了加州大学圣地亚哥分校的管理科学学士学位，并且是CFA特许持有人。
- Daniel Sollof has served as a member of the Board since June 2021 and served as a member of the board of managers of Elite Body Sculpture from October 2018 until the IPO. Mr. Sollof joined VSCP in August 2014 and serves as a General Partner for the firm. In addition to sourcing and evaluating potential investment opportunities, Mr. Sollof works closely with VSCP's portfolio companies. From July 2015 to August 2017, he served as a member of the board of directors of Imedex, Inc. Prior to joining VSCP, Mr. Sollof served as Vice President and Research Analyst for Barclays Capital/Lehman Brothers August 2007 to August 2014, focusing on the Healthcare Facilities and Medical Supplies & Devices Sectors. Prior to Barclays Capital/Lehman Brothers, Mr. Sollof worked as a Valuation and Business Modeling Analyst in the Transaction Advisory Services group at Ernst & Young from September 2005 to July 2007. Mr. Sollof received a B.S. in Management Science from the University of California — San Diego and is a CFA charterholder.
- Caroline Chu
-
Caroline Chu自2021年10月起担任AirSculpt Technologies, Inc.董事会成员。此前，楚女士从2002年6月至2018年2月在高盛 Sachs Group，Inc.工作了16年。曾任Equity Research投资分析师、高盛 Principal Strategies公募投资者及高盛 Sachs Investment Partners投资组合经理兼董事总经理。朱女士还曾于2018年5月至2020年1月担任Alwyne Management LP的股票联席主管和董事总经理。
Caroline Chu has served as a member of Airsculpt Technologies, Inc.'s Board since October 2021. Previously, Ms. Chu spent 16 years at Goldman Sachs Group, Inc. from June 2002 to February 2018. She served as an investment analyst in Equity Research, a public equities investor in Goldman Sachs Principal Strategies and portfolio manager and Managing Director in Goldman Sachs Investment Partners. Ms. Chu also served as Co Head of Equities and Managing Director for Alwyne Management LP from May 2018 to January 2020. - Caroline Chu自2021年10月起担任AirSculpt Technologies, Inc.董事会成员。此前，楚女士从2002年6月至2018年2月在高盛 Sachs Group，Inc.工作了16年。曾任Equity Research投资分析师、高盛 Principal Strategies公募投资者及高盛 Sachs Investment Partners投资组合经理兼董事总经理。朱女士还曾于2018年5月至2020年1月担任Alwyne Management LP的股票联席主管和董事总经理。
- Caroline Chu has served as a member of Airsculpt Technologies, Inc.'s Board since October 2021. Previously, Ms. Chu spent 16 years at Goldman Sachs Group, Inc. from June 2002 to February 2018. She served as an investment analyst in Equity Research, a public equities investor in Goldman Sachs Principal Strategies and portfolio manager and Managing Director in Goldman Sachs Investment Partners. Ms. Chu also served as Co Head of Equities and Managing Director for Alwyne Management LP from May 2018 to January 2020.
- Thomas Aaron
-
Thomas Aaron自2021年10月起担任AirSculpt Technologies, Inc.董事会成员。自2019年11月至2024年11月，Aaron先生担任辛辛那提金融公司（纳斯达克：CINF）的董事会成员，并在2023年和2024年期间担任CINF的审计委员会和薪酬委员会成员。自2019年11月至2024年11月，Aaron先生还担任CINF旗下财产保险公司及其他子公司的董事会成员。2016年至2017年，Aaron先生担任Community Health Systems, Inc.（纽约证券交易所代码：CYH）的财务高级副总裁。Aaron先生于2017年5月被任命为CYH执行副总裁兼首席财务官，并在该职位任职至2019年12月。在加入CYH之前，Aaron先生在德勤拥有32年的杰出职业生涯，主要为国家医疗保健组织等提供审计和咨询服务。Aaron先生是一名注册会计师，拥有肯塔基大学会计学学士学位。
Thomas Aaron has served as a member of Airsculpt Technologies, Inc.'s Board since October 2021. From November 2019 to November 2024, Mr. Aaron served as a member of the board of directors of Cincinnati Financial Corporation (Nasdaq: CINF) and served on CINF's audit committee and the compensation committee during 2023 and 2024. From November 2019 to November 2024, Mr. Aaron also served as a member of the boards of directors of CINF's property casualty insurance companies and other subsidiaries. From 2016 to 2017, Mr. Aaron served as Senior Vice President of Finance of Community Health Systems, Inc. (NYSE: CYH). Mr. Aaron was appointed to serve as Executive Vice President and Chief Financial Officer of CYH in May 2017, a position in which he served through December 2019. Prior to joining CYH, Mr. Aaron had a distinguished, 32 year career at Deloitte leading audit and consulting services to, among others, national healthcare organizations. Mr. Aaron is a Certified Public Accountant and holds a B.S. in Accounting from the University of Kentucky. - Thomas Aaron自2021年10月起担任AirSculpt Technologies, Inc.董事会成员。自2019年11月至2024年11月，Aaron先生担任辛辛那提金融公司（纳斯达克：CINF）的董事会成员，并在2023年和2024年期间担任CINF的审计委员会和薪酬委员会成员。自2019年11月至2024年11月，Aaron先生还担任CINF旗下财产保险公司及其他子公司的董事会成员。2016年至2017年，Aaron先生担任Community Health Systems, Inc.（纽约证券交易所代码：CYH）的财务高级副总裁。Aaron先生于2017年5月被任命为CYH执行副总裁兼首席财务官，并在该职位任职至2019年12月。在加入CYH之前，Aaron先生在德勤拥有32年的杰出职业生涯，主要为国家医疗保健组织等提供审计和咨询服务。Aaron先生是一名注册会计师，拥有肯塔基大学会计学学士学位。
- Thomas Aaron has served as a member of Airsculpt Technologies, Inc.'s Board since October 2021. From November 2019 to November 2024, Mr. Aaron served as a member of the board of directors of Cincinnati Financial Corporation (Nasdaq: CINF) and served on CINF's audit committee and the compensation committee during 2023 and 2024. From November 2019 to November 2024, Mr. Aaron also served as a member of the boards of directors of CINF's property casualty insurance companies and other subsidiaries. From 2016 to 2017, Mr. Aaron served as Senior Vice President of Finance of Community Health Systems, Inc. (NYSE: CYH). Mr. Aaron was appointed to serve as Executive Vice President and Chief Financial Officer of CYH in May 2017, a position in which he served through December 2019. Prior to joining CYH, Mr. Aaron had a distinguished, 32 year career at Deloitte leading audit and consulting services to, among others, national healthcare organizations. Mr. Aaron is a Certified Public Accountant and holds a B.S. in Accounting from the University of Kentucky.
- Kenneth Higgins
-
Kenneth Higgins自2021年10月起担任AirSculpt Technologies, Inc.董事会成员。从2021年4月至2025年12月，Higgins先生担任Northborne Partners，LLC的董事总经理和联合创始人，该公司是一家专注于中间市场的并购咨询公司，他目前自2026年1月起担任该公司的高级顾问。此前，Higgins先生于2016年至2021年在BMO资本市场公司（蒙特利尔银行（纽约证券交易所代码：BMO）的子公司）工作了4.5年。Higgins先生在密歇根大学商学院获得工商管理学士学位，在哈佛法学院获得法学博士学位。
Kenneth Higgins has served as a member of Airsculpt Technologies, Inc.'s Board since October 2021. From April 2021 to December 2025, Mr. Higgins served as the managing director and co founder of Northborne Partners, LLC, a middle market focused mergers and acquisitions advisory firm, where he currently serves as Senior Advisor since January 2026. Previously, Mr. Higgins spent 4.5 years at BMO Capital Markets Corp. (a subsidiary of Bank of Montreal (NYSE: BMO)) from 2016 to 2021. Mr. Higgins received his Bachelor of Business Administration from the University of Michigan School of Business and his Juris Doctor degree from Harvard Law School. - Kenneth Higgins自2021年10月起担任AirSculpt Technologies, Inc.董事会成员。从2021年4月至2025年12月，Higgins先生担任Northborne Partners，LLC的董事总经理和联合创始人，该公司是一家专注于中间市场的并购咨询公司，他目前自2026年1月起担任该公司的高级顾问。此前，Higgins先生于2016年至2021年在BMO资本市场公司（蒙特利尔银行（纽约证券交易所代码：BMO）的子公司）工作了4.5年。Higgins先生在密歇根大学商学院获得工商管理学士学位，在哈佛法学院获得法学博士学位。
- Kenneth Higgins has served as a member of Airsculpt Technologies, Inc.'s Board since October 2021. From April 2021 to December 2025, Mr. Higgins served as the managing director and co founder of Northborne Partners, LLC, a middle market focused mergers and acquisitions advisory firm, where he currently serves as Senior Advisor since January 2026. Previously, Mr. Higgins spent 4.5 years at BMO Capital Markets Corp. (a subsidiary of Bank of Montreal (NYSE: BMO)) from 2016 to 2021. Mr. Higgins received his Bachelor of Business Administration from the University of Michigan School of Business and his Juris Doctor degree from Harvard Law School.
- Michael Doyle
-
Michael Doyle是AirSculpt Technologies, Inc.技术公司董事会的非执行主席。自2025年1月起担任Vesey Street Capital Partners管理合伙人。Doyle先生于2018年创立了MD Healthcare Partners，并担任其首席执行官至2024年12月。此前，Doyle先生曾在Surgery Partners担任多个领导职务，包括2009年至2017年9月的首席执行官，在那里他领导了该组织约15年，并帮助将其从3个地点扩展到超过175个地点。Doyle先生自2021年9月起担任领先的骨科医生组织Orthopedic Solutions Management的主席。他还曾于2019年8月至2025年8月担任领先的消化科医生组织GastroMD的董事长，并于2018年10月至2021年9月担任公司首次公开发行股票前的前身Elite Body Sculpture的董事会成员。
Michael Doyle is the non executive Chairman of Airsculpt Technologies, Inc.'s Board of Directors. He has served as Managing Partner of Vesey Street Capital Partners since January 2025. Mr. Doyle founded MD Healthcare Partners in 2018 and served as its Chief Executive Officer until December 2024. Previously, Mr. Doyle held several leadership positions, including Chief Executive Officer from 2009 to September 2017, at Surgery Partners, where he led the organization for approximately 15 years and helped to scale it from 3 to over 175 locations. Mr. Doyle has served as Chairman of Orthopedic Solutions Management, a leading orthopedic physician organization, since September 2021. He has also served from August 2019 to August 2025 as Chairman of GastroMD, a leading gastroenterologist organization, and from October 2018 to September 2021 as a member of the board of managers of Elite Body Sculpture, the predecessor of the Company prior to its initial public offering. - Michael Doyle是AirSculpt Technologies, Inc.技术公司董事会的非执行主席。自2025年1月起担任Vesey Street Capital Partners管理合伙人。Doyle先生于2018年创立了MD Healthcare Partners，并担任其首席执行官至2024年12月。此前，Doyle先生曾在Surgery Partners担任多个领导职务，包括2009年至2017年9月的首席执行官，在那里他领导了该组织约15年，并帮助将其从3个地点扩展到超过175个地点。Doyle先生自2021年9月起担任领先的骨科医生组织Orthopedic Solutions Management的主席。他还曾于2019年8月至2025年8月担任领先的消化科医生组织GastroMD的董事长，并于2018年10月至2021年9月担任公司首次公开发行股票前的前身Elite Body Sculpture的董事会成员。
- Michael Doyle is the non executive Chairman of Airsculpt Technologies, Inc.'s Board of Directors. He has served as Managing Partner of Vesey Street Capital Partners since January 2025. Mr. Doyle founded MD Healthcare Partners in 2018 and served as its Chief Executive Officer until December 2024. Previously, Mr. Doyle held several leadership positions, including Chief Executive Officer from 2009 to September 2017, at Surgery Partners, where he led the organization for approximately 15 years and helped to scale it from 3 to over 175 locations. Mr. Doyle has served as Chairman of Orthopedic Solutions Management, a leading orthopedic physician organization, since September 2021. He has also served from August 2019 to August 2025 as Chairman of GastroMD, a leading gastroenterologist organization, and from October 2018 to September 2021 as a member of the board of managers of Elite Body Sculpture, the predecessor of the Company prior to its initial public offering.
- Yogesh Jashnani
-
Yogesh Jashnani自2025年1月7日起担任AirSculpt Technologies, Inc.的首席执行官和董事会成员。Jashnani先生在美学、零售和金融行业拥有超过20年的经验。在加入公司之前，Jashnani先生曾担任Sky Zone的首席营收官。2019年至2023年，任理想影像首席商务官。从2017财年到2019财年，Jashnani先生担任领先汽车配件市场营销、洞察和分析高级副总裁一职。在此之前，Jashnani先生是Capital One的副总裁。Jashnani先生拥有威斯康星大学麦迪逊分校生物医学工程理学硕士学位和电气工程理学硕士学位。他还拥有孟买大学电信工程学学士学位。
Yogesh Jashnani has served as Airsculpt Technologies, Inc.'s Chief Executive Officer and a member of the Board since January 7, 2025. Mr. Jashnani has over 20 years of experience in the aesthetics, retail and finance industries. Prior to joining the Company, Mr. Jashnani served as Chief Revenue Officer for Sky Zone. From 2019 through 2023, he served as Chief Commercial Officer of Ideal Image. From fiscal 2017 through 2019, Mr. Jashnani held the position of SVP, Marketing, Insights and Analytics of Advance Auto Parts. Prior to this, Mr. Jashnani was Vice President at Capital One. Mr. Jashnani holds a Master's of Science in Biomedical Engineering and a Master of Science in Electrical Engineering from University of Wisconsin Madison. He also holds a Bachelor of Engineering in Telecommunications Engineering for University of Mumbai. - Yogesh Jashnani自2025年1月7日起担任AirSculpt Technologies, Inc.的首席执行官和董事会成员。Jashnani先生在美学、零售和金融行业拥有超过20年的经验。在加入公司之前，Jashnani先生曾担任Sky Zone的首席营收官。2019年至2023年，任理想影像首席商务官。从2017财年到2019财年，Jashnani先生担任领先汽车配件市场营销、洞察和分析高级副总裁一职。在此之前，Jashnani先生是Capital One的副总裁。Jashnani先生拥有威斯康星大学麦迪逊分校生物医学工程理学硕士学位和电气工程理学硕士学位。他还拥有孟买大学电信工程学学士学位。
- Yogesh Jashnani has served as Airsculpt Technologies, Inc.'s Chief Executive Officer and a member of the Board since January 7, 2025. Mr. Jashnani has over 20 years of experience in the aesthetics, retail and finance industries. Prior to joining the Company, Mr. Jashnani served as Chief Revenue Officer for Sky Zone. From 2019 through 2023, he served as Chief Commercial Officer of Ideal Image. From fiscal 2017 through 2019, Mr. Jashnani held the position of SVP, Marketing, Insights and Analytics of Advance Auto Parts. Prior to this, Mr. Jashnani was Vice President at Capital One. Mr. Jashnani holds a Master's of Science in Biomedical Engineering and a Master of Science in Electrical Engineering from University of Wisconsin Madison. He also holds a Bachelor of Engineering in Telecommunications Engineering for University of Mumbai.
高管简历
中英对照 | 中文 | 英文- Michael Arthur
Michael Arthur自2026年1月5日起担任AirSculpt Technologies, Inc.的首席财务官。在加入公司之前，Arthur先生于2024年10月至2026年1月担任Inspirato Incorporated的首席财务官，并于2023年2月至2024年9月担任Inspirato Incorporated的财务高级副总裁以及FP & A和财务副总裁。在之前的职位上，Arthur先生于2022年6月至2023年1月担任CSC Generation财务和战略副总裁，并于2020年1月至2022年5月担任VFCorporation公司战略和市场情报高级总监以及公司战略和企业发展总监。Arthur先生在北卡罗来纳大学Kenan Flagler商学院获得了理学学士学位和硕士学位，他是一名注册会计师（北卡罗来纳州，2013年–至今）和特许金融分析师（特许持有人，2017年–至今）。
Michael Arthur has served as Airsculpt Technologies, Inc.'s Chief Financial Officer since January 5, 2026. Prior to joining the Company, Mr. Arthur served as the Chief Financial Officer of Inspirato Incorporated from October 2024 to January 2026, and as Senior Vice President, Finance, and Vice President of FP&A and Treasury, of Inspirato Incorporated from February 2023 to September 2024. In prior roles, Mr. Arthur served as Vice President of Finance and Strategy of CSC Generation from June 2022 to January 2023, and as Senior Director, Corporate Strategy and Market Intelligence, and Director, Corporate Strategy and Corporate Development, of VFCorporation from January 2020 to May 2022. Mr. Arthur received his B.S.B.A. and M.A. from the University of North Carolina Kenan Flagler Business School, and he is a certified public accountant (State of North Carolina, 2013 – present) and chartered financial analyst (charter holder, 2017 – present).- Michael Arthur自2026年1月5日起担任AirSculpt Technologies, Inc.的首席财务官。在加入公司之前，Arthur先生于2024年10月至2026年1月担任Inspirato Incorporated的首席财务官，并于2023年2月至2024年9月担任Inspirato Incorporated的财务高级副总裁以及FP & A和财务副总裁。在之前的职位上，Arthur先生于2022年6月至2023年1月担任CSC Generation财务和战略副总裁，并于2020年1月至2022年5月担任VFCorporation公司战略和市场情报高级总监以及公司战略和企业发展总监。Arthur先生在北卡罗来纳大学Kenan Flagler商学院获得了理学学士学位和硕士学位，他是一名注册会计师（北卡罗来纳州，2013年–至今）和特许金融分析师（特许持有人，2017年–至今）。
- Michael Arthur has served as Airsculpt Technologies, Inc.'s Chief Financial Officer since January 5, 2026. Prior to joining the Company, Mr. Arthur served as the Chief Financial Officer of Inspirato Incorporated from October 2024 to January 2026, and as Senior Vice President, Finance, and Vice President of FP&A and Treasury, of Inspirato Incorporated from February 2023 to September 2024. In prior roles, Mr. Arthur served as Vice President of Finance and Strategy of CSC Generation from June 2022 to January 2023, and as Senior Director, Corporate Strategy and Market Intelligence, and Director, Corporate Strategy and Corporate Development, of VFCorporation from January 2020 to May 2022. Mr. Arthur received his B.S.B.A. and M.A. from the University of North Carolina Kenan Flagler Business School, and he is a certified public accountant (State of North Carolina, 2013 – present) and chartered financial analyst (charter holder, 2017 – present).
- Yogesh Jashnani
Yogesh Jashnani自2025年1月7日起担任AirSculpt Technologies, Inc.的首席执行官和董事会成员。Jashnani先生在美学、零售和金融行业拥有超过20年的经验。在加入公司之前，Jashnani先生曾担任Sky Zone的首席营收官。2019年至2023年，任理想影像首席商务官。从2017财年到2019财年，Jashnani先生担任领先汽车配件市场营销、洞察和分析高级副总裁一职。在此之前，Jashnani先生是Capital One的副总裁。Jashnani先生拥有威斯康星大学麦迪逊分校生物医学工程理学硕士学位和电气工程理学硕士学位。他还拥有孟买大学电信工程学学士学位。
Yogesh Jashnani has served as Airsculpt Technologies, Inc.'s Chief Executive Officer and a member of the Board since January 7, 2025. Mr. Jashnani has over 20 years of experience in the aesthetics, retail and finance industries. Prior to joining the Company, Mr. Jashnani served as Chief Revenue Officer for Sky Zone. From 2019 through 2023, he served as Chief Commercial Officer of Ideal Image. From fiscal 2017 through 2019, Mr. Jashnani held the position of SVP, Marketing, Insights and Analytics of Advance Auto Parts. Prior to this, Mr. Jashnani was Vice President at Capital One. Mr. Jashnani holds a Master's of Science in Biomedical Engineering and a Master of Science in Electrical Engineering from University of Wisconsin Madison. He also holds a Bachelor of Engineering in Telecommunications Engineering for University of Mumbai.- Yogesh Jashnani自2025年1月7日起担任AirSculpt Technologies, Inc.的首席执行官和董事会成员。Jashnani先生在美学、零售和金融行业拥有超过20年的经验。在加入公司之前，Jashnani先生曾担任Sky Zone的首席营收官。2019年至2023年，任理想影像首席商务官。从2017财年到2019财年，Jashnani先生担任领先汽车配件市场营销、洞察和分析高级副总裁一职。在此之前，Jashnani先生是Capital One的副总裁。Jashnani先生拥有威斯康星大学麦迪逊分校生物医学工程理学硕士学位和电气工程理学硕士学位。他还拥有孟买大学电信工程学学士学位。
- Yogesh Jashnani has served as Airsculpt Technologies, Inc.'s Chief Executive Officer and a member of the Board since January 7, 2025. Mr. Jashnani has over 20 years of experience in the aesthetics, retail and finance industries. Prior to joining the Company, Mr. Jashnani served as Chief Revenue Officer for Sky Zone. From 2019 through 2023, he served as Chief Commercial Officer of Ideal Image. From fiscal 2017 through 2019, Mr. Jashnani held the position of SVP, Marketing, Insights and Analytics of Advance Auto Parts. Prior to this, Mr. Jashnani was Vice President at Capital One. Mr. Jashnani holds a Master's of Science in Biomedical Engineering and a Master of Science in Electrical Engineering from University of Wisconsin Madison. He also holds a Bachelor of Engineering in Telecommunications Engineering for University of Mumbai.
- Brent Wadman
Brent Wadman自2026年2月13日起担任AirSculpt Technologies, Inc.的总法律顾问。在加入公司之前，Wadman先生于2024年5月至2026年2月期间担任Inspirato Incorporated的总法律顾问。他此前于2018年7月至2022年3月期间担任Messner Reeves LLP的合伙人，并于2014年3月至2017年3月期间担任Stillwater Mining Company的总法律顾问。他在北卡罗来纳大学威尔明顿分校获得人类学学士学位，并在塔尔萨大学法学院获得法学博士学位。
Brent Wadman has served as Airsculpt Technologies, Inc.'s General Counsel since February 13, 2026. Prior to joining the Company, Mr. Wadman served as General Counsel of Inspirato Incorporated from May 2024 to February 2026. He previously served as a partner at Messner Reeves LLP from July 2018 until March 2022 and as general counsel for Stillwater Mining Company from March 2014 until March 2017. He received his bachelor's degree in Anthropology from the University of North Carolina at Wilmington and a Juris Doctorate from the University of Tulsa College of Law.- Brent Wadman自2026年2月13日起担任AirSculpt Technologies, Inc.的总法律顾问。在加入公司之前，Wadman先生于2024年5月至2026年2月期间担任Inspirato Incorporated的总法律顾问。他此前于2018年7月至2022年3月期间担任Messner Reeves LLP的合伙人，并于2014年3月至2017年3月期间担任Stillwater Mining Company的总法律顾问。他在北卡罗来纳大学威尔明顿分校获得人类学学士学位，并在塔尔萨大学法学院获得法学博士学位。
- Brent Wadman has served as Airsculpt Technologies, Inc.'s General Counsel since February 13, 2026. Prior to joining the Company, Mr. Wadman served as General Counsel of Inspirato Incorporated from May 2024 to February 2026. He previously served as a partner at Messner Reeves LLP from July 2018 until March 2022 and as general counsel for Stillwater Mining Company from March 2014 until March 2017. He received his bachelor's degree in Anthropology from the University of North Carolina at Wilmington and a Juris Doctorate from the University of Tulsa College of Law.